Episodes 7
Avg. Duration 20m
Activity Active
Since May 2026
Latest Episode Jun 2026

Publishing Details

Schedule
Every Few Days
Format
Episodic
Consistency
48%
Hosting
anchor.fm

Contact & Outreach

About This Podcast

Every Tuesday, we break down 10 of the most significant biopharma stories and buzzworthy clinical trial breakthroughs from the previous week. The podcast highlights major Phase 2 and Phase 3 trial results, breakthrough therapies, biotech innovations, FDA updates, and emerging treatments shaping the future of medicine. From obesity and cancer to autoimmune disease, neurodegeneration, cardiovascular disease, diabetes, and rare genetic disorders, each episode delivers a fast, accessible look at the data, discoveries, and therapies driving the next generation of healthcare.

Explore Statistics

Recent Episodes

Last Week in Biomedicine | May 23–29 | Part 2 of 2: Apogee Eczema, TG Therapeutics MS

Jun 04, 2026 11m

In Part 2 we cover the remaining clinical trial readouts from the week of May 23–29, 2026 — a Phase 2 atopic dermatitis breakthrough and a Phase 3 multiple sclerosis convenience win.4. Apogee…

Last Week in Biomedicine | May 23–29 | Part 1 of 2: BMS Myeloma, GSK Hep B Cure, Pfizer Lung Cancer

Jun 02, 2026 36m

In Part 1 we cover the three biggest clinical trial readouts from the week of May 23–29, 2026 — including two ASCO 2026 opening-day announcements that reshape oncology.1. Bristol Myers Squibb —…

Last Week in Biomedicine | May 18–22 | Part 2 of 2: Bladder Cancer Conjugate, HPV Cervical Win

May 28, 2026 12m

Part 2 of our May 18–22, 2026 roundup digs into a first-in-class Bicycle Toxin Conjugate for bladder cancer, a non-surgical DNA immunotherapy clearing HPV-driven cervical pre-cancer, anoff-the-shelf…

Last Week in Biomedicine | May 18–22 | Part 1 of 2: Retatrutide Obesity, Sac-TMT Cancer Win

May 26, 2026 19m

This week the biggest story in clinical trial results came out of an obesity trial: Eli Lilly's retatrutide — a once-weekly shot that activates three different appetite-and-metabolism hormones (GIP,…

Last Week in Biomedicine | May 11–15 | Part 2

May 21, 2026 23m

Top 10 significant clinical trial results from last weekPart 2:6. Enterprise Therapeutics (private) — ETD001 (inhaled ENaCblocker) for cystic fibrosis (Phase 2)7. Daré Bioscience ($DARE) — Ovaprene…

Last Week in Biomedicine | May 11–15 | Part 1

May 19, 2026 12m

Top 10 significant clinical trial results from last weekPart 1:1. REGENXBIO ($RGNX) — RGX-202 microdystrophin gene therapy for Duchenne muscular dystrophy (Phase 3)2. Alkermes ($ALKS) — LUMRYZ…

Last Week in Biomedicine | May 4-9

May 12, 2026 29m

Last week's biggest biotech story: Cytokinetics hit both dual primary endpoints in the ACACIA-HCM pivotal Phase 3 trial of aficamten in non-obstructive hypertrophic cardiomyopathy — the first cardiac…

Frequently Asked Questions

How many episodes does Last Week in Biomedicine have?

Last Week in Biomedicine has published 7 episodes since May 2026, covering topics in Health & Fitness, Medicine.

Is Last Week in Biomedicine still active?

Last Week in Biomedicine is currently active with new episodes every few days. Average episode length is 20m.

How do I contact Last Week in Biomedicine for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for Last Week in Biomedicine, including email and social media links.

Similar Podcasts